재발성 다발성 경화증(RMS)에서 테리플루노미드와 비교한 페네브루티닙의 효능 및 안전성을 평가하기 위한 연구 (FENhance)
재발성 다발성 경화증이 있는 성인 환자에서 테리플루노마이드와 비교하여 페네브루티닙의 효능 및 안전성을 평가하기 위한 3상 다기관 무작위, 이중 맹검, 이중 더미, 병렬 그룹 연구
A study to evaluate the efficacy and safety of fenebrutinib on disability progression and relapse rate in adult participants with RMS. Eligible participants will be randomized in a 1:1 ratio to receive either fenebrutinib or teriflunomide. At the end of the double-blind treatment (DBT) phase (after disclosure of the DBT results), the Sponsor will determine whether or not to initiate the open-label extension (OLE) phase of the study.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Tbilisi, 그루지야, 0179
- Khechinashvili University Hospital
-
Tbilisi, 그루지야, 0114
- New Hospitals
-
Tbilisi, 그루지야, 0114
- Pineo Medical Ecosystem
-
Tbilisi, 그루지야, 0160
- MediClab Georgia
-
Tbilisi, 그루지야, 0159
- St. Michael hospital
-
-
-
-
-
Sittard-Geleen, 네덜란드, 6162 BG
- Zuyderland Medisch Centrum - Sittard Geleen
-
-
-
-
-
Santiago de los Caballeros, 도미니카 공화국, 51000
- NeuroINC
-
Santo Domingo, 도미니카 공화국, 10210
- Hospital Padre Billini
-
-
-
-
-
Berlin, 독일, 13347
- Jüdisches Krankenhaus Berlin
-
Böblingen, 독일, 71034
- Studienzentrum Dr. Bischof GmbH
-
Dresden, 독일, 01307
- Universitätsklinikum "Carl Gustav Carus", Zentrum für Klinische Neurowissenschaften
-
Giessen, 독일, 35385
- Universitätsklinikum Gießen und Marburg GmbH
-
Kiel, 독일, 24105
- Uniklinik Schleswig-Holstein
-
Stuttgart, 독일, 70174
- Praxis Dr. med. Andreas Kowalik, Arzt für Neurologie und Psychiatrie
-
Tübingen, 독일, 72076
- Universitätsklinikum Tübingen, Zentrum für Neurologie
-
Ulm, 독일, 89081
- Universitätsklinikum Ulm
-
Westerstede, 독일, 26655
- Studienzentrum Nordwest Dr med Joachim Springub Herr Wolfgang Schwarz
-
-
-
-
-
Kirov, 러시아 제국, 610007
- Center of Cardiology and Neurology
-
Novosibirsk, 러시아 제국, 630007
- FSBIH Siberian Regional Medical Centre of FMBA of Russia
-
-
Bashkortostan Republic
-
Ufa, Bashkortostan Republic, 러시아 제국, 450005
- Republican clinical hospital named after G.G. Kuvatov
-
-
Sankt-Peterburg
-
Saint Petersburg, Sankt-Peterburg, 러시아 제국, 194291
- Leningrad Regional Clinical Hospital
-
Saint Petersburg, Sankt-Peterburg, 러시아 제국, 197022
- Pavlov State Medical Uni
-
-
Ulyanovsk Oblast
-
Ulyanovsk, Ulyanovsk Oblast, 러시아 제국, 432063
- Ulyanovsk Regional Clinical Hospital
-
-
-
-
Coahuila
-
Saltillo, Coahuila, 멕시코, 25050
- Clinical Research Institute Saltillo
-
-
Mexico CITY (federal District)
-
Mexico City, Mexico CITY (federal District), 멕시코, 03100
- Grupo Medico de Investigacion Clinica Multidisciplinaria
-
Mexico City, Mexico CITY (federal District), 멕시코, 03100
- Health Pharma Professional Research
-
-
Sinaloa
-
Culiacán, Sinaloa, 멕시코, 80020
- Neurociencias Estudios Clinicos S.C.
-
-
Tlaxcala
-
Mexico, Tlaxcala, 멕시코, 06726
- Hospital General de Mexico
-
-
-
-
Alabama
-
Birmingham, Alabama, 미국, 35233
- University of Alabama Birmingham
-
Homewood, Alabama, 미국, 35209
- Alabama Neurology Associates
-
-
Arizona
-
Phoenix, Arizona, 미국, 85032
- Center for Neurology and Spine - Phoenix - Hunt - PPDS
-
-
California
-
Carlsbad, California, 미국, 92011
- Profound Research, LLC
-
Irvine, California, 미국, 92697
- University of California Irvine
-
Pasadena, California, 미국, 91106
- Quantum Clinical Research, Inc
-
-
Colorado
-
Aurora, Colorado, 미국, 80045
- University of Colorado Denver
-
Denver, Colorado, 미국, 80209
- Mountain View Clinical Research
-
Fort Collins, Colorado, 미국, 80528
- Advanced Neurology of Colorado, LLC
-
-
Florida
-
Maitland, Florida, 미국, 32751
- Neurology Associates, PA; Research Department
-
-
Illinois
-
Highland Park, Illinois, 미국, 60035
- NorthShore University HealthSystem
-
-
Indiana
-
Fort Wayne, Indiana, 미국, 46805
- Fort Wayne Neurological Center
-
-
Louisiana
-
Baton Rouge, Louisiana, 미국, 70810
- The NeuroMedical Center
-
Shreveport, Louisiana, 미국, 71103
- Ochsner LSU Health
-
-
Maryland
-
Baltimore, Maryland, 미국, 21287
- Johns Hopkins University School Of Medicine; Outpatient Center
-
-
Massachusetts
-
Worcester, Massachusetts, 미국, 01655
- University of Massachusetts Medical School
-
-
Michigan
-
Detroit, Michigan, 미국, 48202
- Henry Ford Health System
-
-
Missouri
-
St Louis, Missouri, 미국, 63110
- Washington University School of Medicine
-
-
New Jersey
-
Teaneck, New Jersey, 미국, 07666
- Holy Name Hospital; Institute For Clinical Research
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87131
- University of New Mexico; MS Specialty Clinic
-
-
Ohio
-
Centerville, Ohio, 미국, 45459
- Miami Valley Hospital South; Dayton Physician's Office
-
Columbus, Ohio, 미국, 43214
- OhioHealth
-
Columbus, Ohio, 미국, 43235
- The Boster Center for Multiple Sclerosis a Singlepoint Healthcare Company
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73104
- Oklahoma Medical Research Foundation; MS Center of Excellence
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, 미국, 18015
- St. Luke's University Health network
-
-
South Carolina
-
Greenville, South Carolina, 미국, 29605
- Premier Neurology
-
-
Tennessee
-
Knoxville, Tennessee, 미국, 37920
- New Orleans Center for Clinical Research
-
-
Texas
-
Plano, Texas, 미국, 75024
- North Texas Institute of Neurology and Headache NextStage Clinical Research Clinic
-
Sherman, Texas, 미국, 75092
- Texas Institute for Neurological Disorders
-
-
Virginia
-
Vienna, Virginia, 미국, 22182
- Multiple Sclerosis Center of Greater Washington
-
-
Washington
-
Kirkland, Washington, 미국, 98034
- Evergreen MS Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, 미국, 53215
- Wheaton Franciscan Healthcare - St. Francis Outpatient Center; Center for Neurological Disorders
-
-
-
-
-
Shtip, 북 마케도니아, 2000
- Clinical Hospital Stip
-
Skopje, 북 마케도니아, 1000
- PHO General City Hospital 8th September Center for dialysis
-
Skopje, 북 마케도니아, 1000
- University Clinic for Neurology - Skopje
-
-
-
-
-
Belgrade, 세르비아, 11000
- University Clinical Center of Serbia
-
-
-
-
-
Bern, 스위스, 3010
- Inselspital Bern Medizin Neurologie
-
Lugano, 스위스, 6903
- Ospedale Regionale di Lugano - Civico
-
-
-
-
-
Barcelona, 스페인, 08035
- Hospital Universitari Vall d'Hebron
-
Madrid, 스페인, 28034
- Hospital Ramon y Cajal
-
Madrid, 스페인, 28007
- Hospital General Universitario Gregorio Marañon
-
Madrid, 스페인, 28040
- Fundacion Jimenez Diaz
-
Madrid, 스페인, 28006
- Hospital Universitario de la Princesa
-
Málaga, 스페인, 29010
- Hospital Regional Universitario de Malaga ? Hospital General
-
Seville, 스페인, 41009
- Hospital Universitario Virgen Macarena
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, 스페인, 08907
- Hospital Universitari de Bellvitge
-
-
Madrid
-
Pozuelo de Alarcón, Madrid, 스페인, 28223
- Hospital Quiron de Madrid
-
-
Murcia
-
EL Palmar (EL Palmar), Murcia, 스페인, 30120
- Hospital Universitario Virgen de Arrixaca
-
-
Pontevedra
-
Vigo, Pontevedra, 스페인, 36213
- Hospital Alvaro Cunqueiro
-
-
-
-
-
Buenos Aires, 아르헨티나, C1424
- Centro de Especialidades Neurológicas y Rehabilitación - CENyR
-
Buenos Aires, 아르헨티나, C1405BCH
- IME - Instituto Médico Especializado
-
Buenos Aires, 아르헨티나, C1182ACA
- Neurologia Infantil Buenos Aires (NIBA)
-
C. A. B. A., 아르헨티나, C1055AAF
- CIER
-
Rosario, 아르헨티나, 2000
- Diagnostico Medico Oroño
-
San Juan, 아르헨티나, J5400CEP
- Cer San Juan
-
San Miguel de Tucumán, 아르헨티나, T4000AXL
- Centro de Investigaciones Médicas Tucuman
-
-
-
-
-
Dnipro, 우크라이나, 49027
- SI USSRI of Medical and Social Problems of Disabilities of MOHU
-
Kharkiv, 우크라이나, 61068
- Ams of Ukraine
-
Kyiv, 우크라이나, 03037
- Medical Center of Private Execution First Private Clinic
-
Kyiv, 우크라이나, 02123
- Medical Center Dopomoga Plus
-
Lviv, 우크라이나, 79010
- Lviv Regional Clinical Hospital
-
Lviv, 우크라이나, 79029
- "Neurofocus" LLC
-
Odesa, 우크라이나, 65117
- Odesa Regional Clinical Hospital
-
Vinnytsi, 우크라이나, 21009
- Medical Clinical Research Center of Medical Center LLC Health Clinic
-
Zaporizhzhya, 우크라이나, 69600
- Municipal Non-profit Enterprise Zaporizhzhya Regional Hospital Zaporizhzhya Regional Council
-
Zaporizhzhya, 우크라이나, 69035
- LCC "Medical center "Unimed"
-
-
KIEV Governorate
-
Vinnytsia, KIEV Governorate, 우크라이나, 21009
- Salutem Medical Center
-
-
Tavria Okruha
-
Dnipro, Tavria Okruha, 우크라이나
- Separated structural unit ?University hospital? of Dnipro State Medical University
-
-
-
-
Apulia
-
Foggia, Apulia, 이탈리아, 71100
- AO.U. Policlinico Riuniti Foggia
-
-
Campania
-
Naples, Campania, 이탈리아, 80131
- AOU Seconda Università degli Studi
-
Naples, Campania, 이탈리아, 80138
- AOU Policlinico - Università L. Vanvitelli
-
-
Emilia-Romagna
-
Parma, Emilia-Romagna, 이탈리아, 43126
- A.O.U. di Parma
-
-
Lazio
-
Rome, Lazio, 이탈리아, 00185
- Policlinico Umberto I
-
Rome, Lazio, 이탈리아, 00189
- Azienda Ospedaliera Sant'Andrea
-
Rome, Lazio, 이탈리아, 00133
- Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla
-
-
Lombardy
-
Bergamo, Lombardy, 이탈리아, 24127
- ASST PAPA GIOVANNI XXIII Neurologia USS Malattie Autoimmuni Centro Sclerosi Multipla
-
Milan, Lombardy, 이탈리아, 20132
- IRCCS Ospedale San Raffaele
-
-
Piedmont
-
Mondovì (CN), Piedmont, 이탈리아, 12084
- Ospedale Regina Montis Regalis
-
-
Sicily
-
Catania, Sicily, 이탈리아, 95123
- AOU Policlinico V. Emanuele - P.O G. Rodolico
-
-
Veneto
-
Padova, Veneto, 이탈리아, 35128
- Azienda Ospedaliera di Padova
-
-
-
-
-
Beijing, 중국
- Beijing Tiantan Hospital,Capital Medical University
-
Beijing, 중국, 100034
- Peking University First Hospital
-
Changchun, 중국, 130021
- the First Hospital of Jilin University
-
Changsha, 중국, 410008
- Xiangya Hospital Central South University
-
Chengdu, 중국, 610041
- West China Hospital, Sichuan University
-
Chongqing, 중국, 400016
- The First Affiliated Hospital, Chongqing Medical University
-
Guangzhou, 중국, 510080
- The First Affiliated Hospital of Sun Yat-sen University
-
Guangzhou, 중국, 510260
- The second Affiliated Hospital of Guangzhou Medical University
-
Guiyang, 중국
- The affiliated Hospital of Guiyang Medical College
-
Kunming, 중국, 650021
- The First People?s Hospital of Yunnan Province
-
Shijiazhuang, 중국, 05000
- The Second Hospital of Hebei Medical University
-
Suzhou, 중국, 215031
- The First Affiliated Hospital of Soochow University
-
Taiyuan, 중국
- 1st Affiliated Hospital of Shanxi Medical University
-
Tianjin, 중국, 300052
- Tianjin Medical University General Hospital
-
Wuhan, 중국, 430030
- Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
-
Xi'an, 중국
- Tangdu Hospital, The Fourth Military Medical University
-
Ürümqi, 중국, 830000
- Xinjiang People Hospital
-
-
-
-
-
Nairobi, 케냐, 00100
- The Aga Khan University-Kenya.
-
-
-
-
-
Mannouba, 튀니지, 2010
- Hopital Razi
-
Monastir, 튀니지, 5000
- Fattouma Bourguiba Hospital
-
Sfax, 튀니지, 3029
- Hospital Habib Bourguiba
-
-
-
-
-
Bellavista, 페루, Callao 2
- Hospital IV Alberto Sabogal Sologuren
-
La Victoria, Lima, 페루, Lima 13
- Hospital Nacional Guillermo Almenara Irigoyen
-
Lima, 페루, Lima 29
- Hospital Maria Auxiliadora
-
Lima, 페루, 15018
- Hospital Nacional Dos de Mayo
-
Lima, 페루, Lima 01
- Clinica Internacional Sede Lima
-
Pueblo Libre, 페루, Lima 21
- Clinica Centenario Peruano Japonesa
-
-
-
-
-
Braga, 포르투갈, 4710-243
- Hospital de Braga
-
Coimbra, 포르투갈, 3000-075
- HUC
-
Lisbon, 포르투갈, 1500-650
- Hospital da Luz
-
Lisbon, 포르투갈, 1169-050
- Hospital Santo Antonio dos Capuchos
-
Porto, 포르투갈, 4200-319
- Hospital de Sao Joao
-
Porto, 포르투갈, 4099-001
- Hospital Geral de Santo Antonio
-
Santa Maria da Feira, 포르투갈, 4520-211
- Centro Hospitalar Entre o Douro e Vouga E.P.E. - Hospital de São Sebastião
-
-
-
-
-
?ory, 폴란드, 44-240
- ProNeuro Centrum Medyczne
-
Bydgoszcz, 폴란드, 85-796
- Neurocentrum Bydgoszcz sp. z o.o
-
Katowice, 폴란드, 40-568
- Care Clinic
-
Krosno, 폴란드, 38-400
- MT Medic Krosno
-
Lodz, 폴란드, 90-324
- Centrum Neurologii Krzysztof Selmaj
-
Lublin, 폴란드, 20-492
- Rodzinne Centrum Medyczne Lubimed.pl
-
Warsaw, 폴란드, 02-957
- Instytut Psychiatrii i Neurologii II Klinika Neurologiczna
-
Zabrze, 폴란드, 41-800
- IBISMED Wielospecjalistyczne Centrum Medyczne
-
-
-
-
-
Helsinki, 핀란드, 00290
- Helsinki University Central Hospital
-
-
-
-
-
Budapest, 헝가리, 1033
- Clinexpert Kft.
-
Budapest, 헝가리, 1044
- S-Medicon Egeszsegugyi Szolgaltato Kft.
-
Eger, 헝가리, 3300
- Markhot Ferenc Oktatokorhaz és Rendelointezet
-
Kistarcsa, 헝가리, 2143
- Pest Megyei Flor Ferenc Korhaz
-
Szeged, 헝가리, 6725
- Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ
-
-
-
-
-
Hong Kong, 홍콩
- Pamela Youde Nethersole Eastern Hospital
-
Shatin, New Territories, 홍콩
- Prince of Wales Hospital
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Expanded Disability Status Scale (EDSS) score of 0 - 5.5 at screening
- A diagnosis of RMS in accordance with the revised 2017 McDonald Criteria
- Ability to complete the 9-Hole Peg Test (9-HPT) for each hand in < 240 seconds
- Ability to perform the Timed 25-Foot Walk Test (T25FWT) in < 150 seconds
- For female participants of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and refrain from donating eggs
- For male participants: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and refrain from donating sperm
OLE Inclusion Criteria:
- Completed the DBT phase of the study (remaining on study treatment; no other disease-modifying therapy (DMT) administered) and who, in the opinion of the investigator, may benefit from treatment with fenebrutinib
- Participants randomized to the teriflunomide treatment arm during the DBT phase must undergo the accelerated teriflunomide elimination procedure (ATEP) prior to the first administration of open-label fenebrutinib
- For female participants of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and refrain from donating eggs
- For male participants: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and refrain from donating sperm
Exclusion Criteria:
- Disease duration of > 10 years from the onset of symptoms and an EDSS score at screening < 2.0
- Female participants who are pregnant or breastfeeding, or intending to become pregnant
- Male participants who intend to father a child during the study
- A diagnosis of primary progressive multiple sclerosis (PPMS) or non-active secondary progressive multiple sclerosis (SPMS)
- Any known or suspected active infection at screening, including but not limited to a positive screening test for hepatitis B (HBV) and hepatitis C (HCV), an active or latent or inadequately treated infection with tuberculosis (TB), a confirmed or suspected progressive multifocal leukoencephalopathy (PML)
- History of cancer including hematologic malignancy and solid tumors within 10 years of screening
- Known presence of other neurological disorders, that could interfere with the diagnosis of MS or assessments of efficacy or safety during the study and clinically significant cardiovascular, psychiatric, pulmonary, renal, hepatic, endocrine, metabolic or gastrointestinal (GI) disease
- Rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption
- Hypoproteinemia
- Acute liver disease
- Chronic liver disease unless considered stable for > 6 months
- Presence of cirrhosis (Child-Pugh Class A, B, or C) or Gilbert's Syndrome
- Participants with significantly impaired bone marrow function or significant anemia, leukopenia, neutropenia or thrombocytopenia
- Any concomitant disease that may require chronic treatment with systemic corticosteroids or immunosuppressants during the course of the study
- History of alcohol or other drug abuse within 12 months prior to screening
- History of or currently active primary or secondary (non-drug-related) immunodeficiency, including known history of human immunodeficiency virus (HIV) infection
- Inability to complete an MRI scan
- Adrenocorticotropic hormone or systemic corticosteroid therapy within 4 weeks prior to screening (inhaled and topical corticosteroids are allowed)
- Receipt of a live-attenuated vaccine within 6 weeks prior to randomization
- Any previous treatment with immunomodulatory or immunosuppressive medication without an appropriate washout period
OLE Exclusion Criteria:
- Acute liver disease
- Chronic liver disease unless considered stable for > 6 months
- Cirrhosis (Child-Pugh Class A, B, or C)
- Gilbert's syndrome
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Fenebrutinib
Participants will receive oral (PO) fenebrutinib, with teriflunomide-matching placebo. |
Participants will receive fenebrutinib. Participants will receive teriflunomide-matching placebo or fenebrutinib-matching placebo. |
|
활성 비교기: Teriflunomide
Participants will receive PO teriflunomide, with fenebrutinib-matching placebo in a blinded fashion. |
Participants will receive teriflunomide-matching placebo or fenebrutinib-matching placebo. Participants will receive teriflunomide. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
연간 재발률(ARR)
기간: 최소 96주
|
최소 96주
|
2차 결과 측정
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
복합 12주 확인된 장애 진행 시작까지의 시간(cCDP12)
기간: 최소 96주
|
최소 96주
|
|
복합 24주 확인된 장애 진행 시작까지의 시간(cCDP24)
기간: 최소 96주
|
최소 96주
|
|
12주 확인된 장애 진행 시작까지의 시간(CDP12)
기간: 최소 96주
|
최소 96주
|
|
24주 확인된 장애 진행 시작까지의 시간(CDP24)
기간: 최소 96주
|
최소 96주
|
|
지정된 시점에서 페네브루티닙의 혈장 농도
기간: 최대 4.5년
|
최대 4.5년
|
|
복합 재발 활동과 무관하게 12 주 동안의 복합적으로 개시 될 시간 (Cpira12)
기간: 최소 96 주
|
최소 96 주
|
|
부작용(AEs)이 발생한 참가자 비율
기간: 최대 4.5년
|
최대 4.5년
|
|
Total Number of T1 Gadolinium Enhancing (Gd+) Lesions, New and/or Enlarging T2-weighted Lesions, as Detected by Magnetic Resonance Imaging (MRI)
기간: Baseline, Weeks 12, 24, 48 and 96
|
Baseline, Weeks 12, 24, 48 and 96
|
|
Percentage Change in Total Brain Volume From Week 24 as Assessed by MRI
기간: From Week 24 to Week 96
|
From Week 24 to Week 96
|
|
Time to Onset of 12-week Confirmed 4-point Worsening in Symbol Digit Modality Test (SDMT) Score
기간: Minimum of 96 weeks
|
Minimum of 96 weeks
|
|
Change in Participant-reported Physical Impacts of Multiple Sclerosis (MS), as Measured by the Multiple Sclerosis Impact Scale (29-item), Version 2 (MSIS-29) Physical Scale
기간: Baseline, Weeks 12, 24, 36, 48, 60, 72, 84 and 96
|
Baseline, Weeks 12, 24, 36, 48, 60, 72, 84 and 96
|
|
Percent Change From Baseline to Week 48 in the Concentration of Blood Neurofilament Light Chain (NfL)
기간: Baseline, Week 48
|
Baseline, Week 48
|
공동 작업자 및 조사자
수사관
수사관
- 연구 책임자: Clinical Trials, Hoffmann-La Roche
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- GN41851
- 2019-004857-10 (EudraCT 번호)
- 2019 (미국 NIH 보조금/계약)
- 2022-502609-14-00 (씨티스)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data_sharing
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .